For hepatocellular carcinoma (HCC), the common methods of screening high risk patients by alpha-fetoprotein (AFP) and ultra-sonography has been shown to result in earlier detection and consequently more easily treatable tumors and longer survival. The gene discussed is AFP; the disease is hepatocellular carcinoma.